Major drivers of the abnormal nature of tumor vasculature include inflammation, the composition of the extracellular matrix (ECM), and the accumulation of pro-angiogenic factors such as vascular-endothelial growth factor (VEGF)-A, in the tumor microenvironment (TME) [6]. The gene discussed is VEGFA; the disease is neoplasm.